Gianluca Campo to Percutaneous Coronary Intervention
This is a "connection" page, showing publications Gianluca Campo has written about Percutaneous Coronary Intervention.
Connection Strength
1.878
-
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study. JACC Cardiovasc Interv. 2019 10 28; 12(20):2079-2088.
Score: 0.241
-
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study). J Invasive Cardiol. 2018 Apr; 30(4):133-137.
Score: 0.217
-
[Coronary revascularization in patients with ST-elevation myocardial infarction and multivessel disease]. G Ital Cardiol (Rome). 2017 Dec; 18(12):845-853.
Score: 0.212
-
Prospective Identification of Stent Fracture by Enhanced Stent Visualization System During Percutaneous Coronary Intervention. Circ J. 2016 Dec 22; 81(1):82-89.
Score: 0.198
-
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(4):203-210.
Score: 0.064
-
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Circ Cardiovasc Interv. 2019 09; 12(9):e007705.
Score: 0.060
-
Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study. EuroIntervention. 2019 May 20; 15(1):108-115.
Score: 0.059
-
Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study. Minerva Cardioangiol. 2019 Apr; 67(2):94-101.
Score: 0.058
-
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study. JACC Cardiovasc Interv. 2018 08 13; 11(15):1482-1491.
Score: 0.055
-
Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. N Engl J Med. 2018 07 19; 379(3):250-259.
Score: 0.055
-
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial. EuroIntervention. 2018 03 20; 13(16):1939-1945.
Score: 0.054
-
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes. J Am Coll Cardiol. 2018 03 20; 71(11):1231-1242.
Score: 0.054
-
Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial). Am J Cardiol. 2018 05 01; 121(9):1039-1045.
Score: 0.054
-
How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients. Minerva Cardioangiol. 2018 Aug; 66(4):442-451.
Score: 0.054
-
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial). EuroIntervention. 2018 01 20; 13(13):1561-1564.
Score: 0.054
-
Stent and Dual Antiplatelet Therapy Duration Comparisons in the Setting of a Multicenter Randomized Controlled Trial: Can the Operator Experience Affect the Study Results? J Am Heart Assoc. 2017 12 23; 6(12).
Score: 0.053
-
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial. Eur Respir J. 2017 10; 50(4).
Score: 0.053
-
Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation. Am J Cardiol. 2017 Nov 01; 120(9):1460-1466.
Score: 0.052
-
Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation. Eur Heart J. 2017 04 07; 38(14):1069-1080.
Score: 0.051
-
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease. Thromb Haemost. 2017 03 23; 117(6):1208-1216.
Score: 0.051
-
Mechanistic Role of mPTP in Ischemia-Reperfusion Injury. Adv Exp Med Biol. 2017; 982:169-189.
Score: 0.050
-
Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia). J Am Coll Cardiol. 2014 Feb 18; 63(6):506-12.
Score: 0.040
-
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates. Int J Cardiol. 2019 Feb 15; 277:60-65.
Score: 0.014
-
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study. Cardiology. 2018; 140(2):74-82.
Score: 0.014
-
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial. EuroIntervention. 2017 Aug 04; 13(5):e557-e563.
Score: 0.013